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SUPPLEMENTAL FIGURE LEGENDS 
Fig. S1. Colonization of the bloodstream by the ∆gna and ∆gne2 mutants. 
Colonization of the spleen, liver and kidneys was determined by inoculating CBA/J mice via tail 
vein injection with 107 CFU of either the WT strain (57), the ∆gna mutant (A) or the ∆gne2 mutant 
(B). At 24 hpi, mice were sacrificed, organs were harvested, and the bacterial burden was 
determined by CFU enumeration on LB agar (57, ∆gna and ∆gne2) and LB-Km agar (57 eV, ∆gna 
eV, ∆gna compl., ∆gne2 eV and ∆gne2 compl.). Bacterial numbers are presented as the Log10 
CFU g-1 of tissue. Each data point represents a sample from an individual mouse, and horizontal 
bars indicate the median values. Statistical significance was calculated by the Mann-Whitney test 
(*, P<0.05; ****, P<0.0001; NS, not significant). Abbreviations: 57: WT; eV: empty vector 
(pABBR_Km); compl.: complemented (pABBR_Km-gna and pABBR_Km-gne2). 
 
Fig. S2. Growth curves in LB and M9 minimal media. 
(A) Growth of the WT (57) and its derivative strains in LB broth. (B) Growth of the strains in M9 
minimal medium supplemented with 0.4% glucose and 0.2% casamino acids. All results are the 
mean values and standard deviations of three independent experiments. For ease of reading, 
standard deviations were removed from graphs. The quantification of growth, or growth potential, 
and comparison between strains was performed by calculating the area under the curve of each 
  
growth curve. Abbreviation: 57: WT; compl.: complemented (pABBR_Km-gna, pABBR_Km-gne2 
and pABBR_Km-a/e2). 
 
Fig. S3. Resistance to normal human serum. 
Survival in 90% normal human serum (NHS) and growth in 90% heat-inactivated human serum 
(HI). A total of 107 CFU ml-1 of the WT (57) and either the ∆gna (A) or the ∆gne2 (B) strains was 
incubated in either 90% NHS and HI, and the number of CFUs was quantified by CFU 
enumeration on LB agar every hour. Since no CFUs were recovered from strains ∆gna, ∆gna eV, 
∆gne2 and ∆gne2 eV incubated with 90% NHS, no statistical tests were performed for these 
groups. The dashed line corresponds to the limit of detection. All results are the mean values and 
standard deviations of three independent experiments. Statistical significance was calculated by 
the Student’s t-test (B-C, HI) (NS, not significant). Abbreviations: 57: WT; eV: empty vector 
(pABBR_Km); compl.: complemented (pABBR_Km-gna and pABBR_Km-gne2). 
 
Fig. S4. Capsule production depends on the gna-gne2 (a/e2) locus 
(A) Microscopic analysis of capsule production. Maneval’s staining of bacteria cultured for 24 h 
on LB agar plates. Images are representative of three independen experiments. (B) Analysis of 
the polysaccharides from lysates of bacteria cultured for 24 h on LB agar plates by SDS-PAGE 
and stained with 0.1% Alcian blue (section of the gel corresponding to the capsular 
polysaccharides). The strain AB5075 ∆wzc was used as a negative control. (C) Pellet of the 
strains following centrifugation of the overnight cultures normalized to an OD600 of 1.0. The 57, 
AB5075 and the complemented strains present a thick and loose pellet, suggesting capsule 
production, while all the mutant strains show a tight and sticky pellet, which is indicative of non-
capsulated strains. (D) Colony morphology of the strains cultured on BHI Congo red plates for 48 
h at 37°C. (E-F) Autoaggregation assay. Cultures of WT (57) and gna (E) and gne2 (F) were 
standardized in 10 ml of LB to an OD600 of 2.0 in a culture tube and incubated statically at 37°C 
for 4 h. A 200-μl sample was taken 1 cm below the surface at time 0 and 4 h post-inoculation for 
  
OD600 measurement. The percent autoaggregation was determined by dividing the OD600 value 
of the aggregated cells by the OD 600 value of a control growth tube. The MDR strain AB5075 and 
its isogenic wzc mutant were used as controls (B-D). All results are the mean values and standard 
deviations of three independent experiments. Images are representative of three independent 
experiments (A-D). Statistical significance was calculated by the one-way ANOVA with Tukey’s 
multiple comparisons test (D and E) (**, P <0.01; ***, P <0.005; NS, Not significant). Abbreviations: 
57: WT; eV: empty vector (pABBR_Km); compl.: complemented (pABBR_Km-gna, pABBR_Km-
gne2 and pABBR_Km-a/e2). 
 
Fig. S5. The gna-gne2 (a/e2) locus is important for twitching motility 
(A) Twitching motility of the bacterial strains cultured to an OD600 2.0 and an aliquot was stabbed 
to the bottom of a 1% EIKEN agar plate, then incubated at 37°C for 18 h. Twitching motility images 
are representative of three independent experiments. The red bars mark the twitching motility 
diameter. The AB5075 ∆pilT mutant was used as negative control. Images are representative of 
three independent experiments. (B, C, D) Quantification of the twitching diameter (in mm) from 
three independent experiments. The MDR strain AB5075 and its isogenic wzc and pilT mutants 
were used as controls (A-D). All results are the mean values and standard deviations of three 
independent experiments. Statistical significance was calculated by the one-way ANOVA with 
Tukey’s multiple comparisons test (B, C, D) (*, P <0.05; ***, P <0.005; ****, P <0.001; NS, Not 
significant). Abbreviations: 57: WT; eV: empty vector (pABBR_Km); compl.: complemented 
(pABBR_Km-gna and pABBR_Km-gne2). 
 
Fig. S6. The gna-gne2 (a/e2) locus is important maintain the cell envelope integrity 
(A, B) Minimal inhibitory concentration (MIC) of vancomycin on the WT (57) and its derivative 
strains. MIC values were determined by E-test. (C) Growth of the strains on MacConkey plates. 
Strains were cultured to an OD600 of 0.6 and normalized to 107 CFU ml-1 and serial dilutions were 
spotted on MacConkey plates. Images are representative of three independent experiments. (D) 
Colony morphology of the strains cultured on LB agar supplemented with BCIP-Toluidine (XP), a 
substrate of the periplasmic alkaline phosphatase PhoA. Images are representative of three 
  
independent experiments. (E, F) Survival in the presence of polymyxin B (1 µg ml-1). The number 
of surviving CFUs was quantified by CFU enumeration of LB agar at 15-, 30- and 60 mins p.i. The 
MDR strain AB5075 and its isogenic wzc mutant were used as controls (C,D). All results are the 
mean values and standard deviations of three independent experiments. Statistical significance 
was calculated by the one-way ANOVA with Tukey’s multiple comparisons test (A) (*, P <0.05; **, 
P <0.01; ***, P <0.005; NS, Not significant). Abbreviations: 57: WT; eV: empty vector 
(pABBR_Km); compl.: complemented (pABBR_Km-gna and pABBR_Km-gne2). 
 
 
Fig. S7. Lipooligosaccharide biosynthesis is influence by the gna-gne2 (a/e2) locus. 
Analysis of LOS extracted from of bacterial cultures cultured to mid-log phase and separated by 
SDS-PAGE, and stained with Pro-Q emerald 300 Lipopolysaccharide gel stain kit. The E. coli 
MG1655 (rough LPS) was used as a positive control. Images are representative of three 
independent experiments. Abbreviations: 57: WT; compl.: complemented (pABBR_Km-a/e2). 
 
Fig. S8. Cell envelope hydrophobicity and the envelope stress response (ESR) are 
controlled by the gna-gne2 (a/e2) locus. 
(A-C) Bacterial adherence to hydrocarbons. Approximately 107 CFU ml-1 were incubated with 
either 25% n-octane (A; ∆a/e2 mutant) or hexadecane (B; ∆gna and C; ∆gne2) and the number 
of CFUs from the aqueous phase were recovered at 15 mins post-inoculation. An increase in the 
cell envelope hydrophobicity is represented by a lower number of CFUs recovered from the 
aqueous phase. (D-E) Expression of genes involved in the envelope stress response (ESR, dsbA, 
degP, baeR and rstA) between WT, ∆gna (F), ∆gne2 (G), and their respective complemented 
strain. Gene expression was evaluated by qRT-PCR and compared between the WT, the mutants 
and the complemented strain. The dashed line corresponds to the cutoff for a significant 
difference in expression. All results are the mean values and standard deviations of three 
independent experiments. Statistical significance was calculated by the one-way ANOVA with 
Tukey’s multiple comparisons test (A-C) and by the Student’s t-test (D,E) (*, P<0.05; **, P<0.01; 
****, P<0.0001; NS, not significant). Abbreviations: 57, WT; eV, empty vector (pABBR_Km); 
  
compl.: complemented (pABBR_Km-a/e2, pABBR_Km-gna and pABBR_Km-gne2). 
 
Fig. S9. Resistance to antibiotics is influenced by the gna. 
(A) Minimal inhibitory concentration (MIC) of amoxicillin, gentamicin and imipenem, on WT (57) 
and its derivative strains. MIC values were determined by the E-test method. (B) Percent survival 
in the presence of a defined concentration of antibiotic. A total of 107 CFU ml-1 were incubated in 
the presence of different antibiotics and the percent survival was determined by dividing the 
number of CFUs recovered from the antibiotic challenge by the number of CFUs recovered from 
the corresponding untreated sample. All results are the mean values and standard deviations of 
three independent experiments. Statistical significance was calculated by the one-way ANOVA 
with Tukey’s multiple comparisons test (*, P<0.05; **, P<0.01; ***, P<0.005; ****, P<0.0001; NS, 
not significant). Abbreviations: 57, WT; eV: empty vector (pABBR_Km); compl.: complemented 
(pABBR_Km-gna). 
 
Fig. S10. Resistance to antibiotics is influenced by the gne2. 
(A) Minimal inhibitory concentration (MIC) of amoxicillin, gentamicin and imipenem, on WT (57) 
and its derivative strains. MIC values were determined by the E-test method. (B) Percent survival 
in the presence of a defined concentration of antibiotic. A total of 107 CFU ml-1 were incubated in 
the presence of different antibiotics and the percent survival was determined by dividing the 
number of CFUs recovered from the antibiotic challenge by the number of CFUs recovered from 
the corresponding untreated sample. All results are the mean values and standard deviations of 
three independent experiments. Statistical significance was calculated by the one-way ANOVA 
with Tukey’s multiple comparisons test (*, P<0.05; **, P<0.01; ***, P<0.005; ****, P<0.0001; NS, 













S1 Table. A. baumannii strain AB0057 Gna and Gne2 closest homologs. 
Proteins Predicted function Domain Homolog (species) 












WpbP                          
(P. aeruginosa) 99 / 75 / 87 
TviB                                    










WpbO                                               
(P. aeruginosa) 98 / 73 / 86 
TviC                                                  
(S. Typhi) 99 / 66 / 81 
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   S2 Table. Genes belonging to the KL4 locus and their associated.  
Gene Function Fitness defect
a 
Log2 P value 
wzc Protein tyrosine kinase; involved in capsule export -6.2 0.002 
wzb Low molecular weight protein tyrosine phosphatase; involved in capsule export -8.3 0.06 
wza Outer membrane protein; involved in capsule export -8.2 0.04 
gna 
(tviB) UDP-N-acetylglucosamine C-6 dehydrogenase -6.9 0.053 
gne2 
(tviC) UDP-N-acetylglucosaminuronic acid C-4 epimerase -8.8 0.002 
wzx Putative oligosaccharide-unit translocase NAb  
ptr1 Predicted pyruvyltransferase NA  
gtr10 Predicted glycosyltransferase -1.7 0.007 
wzy Predicted oligosaccharide-unit polymerase -8.2 0.1 
gtr11 Predicted glycosyltransferase -1.2 0.45 
gtr12 Predicted glycosyltransferase -7.3 0.009 
qnr UDP-N-acetyl-D-quinovosamine biosynthesis protein -4.1 6.8e-5 
itrB1 Predicted initiating transferase for oligosaccharide synthesis -6.7 0.04 
atr3 Predicted acetyl- or acyl- transferase -7.3 0.005 
gdr UDP-N-acetyl-glucosamine 4,6-dehydratase -5.0 3.6e-6 
gne3 Predicted UDP-glucosamine-4-epimerase -3.9 0.0004 
atr4 Predicted acetyl- or acyl- transferase -3.5 0.06 
atr5 Predicted acetyl- or acyl- transferase -6.9 0.004 
galU UTP-glucose-1-phosphate uridylyltransferase -5.3 0.0006 
ugd UDP-glucose 6-dehydrogenase -3.8 0.005 
gpi Glucose-6-phosphate isomerase -5.0 7.3e-5 
gne1 Predicted UDP-glucosamine-4-epimerase -5.8 0.005 
pgm Phosphoglucomutase/phosphomannomutase -1.6 0.0008 
  a Calculated fitness defect in the spleen according to Crepin et al. 2018 (Crépin et al., 2018) 




S3 Table. Strains and plasmids used in this study. 
Strains Characteristic(s)a Source or reference 
E. coli   
MGN-617 hi thr leu tonA lacY glnV supE ∆asdA4 recA::RP4 
2-Tc::Mu [pir]; Kmr 
(Dozois et al., 2000) 
MG1655 F− lambda− ilvG rfb-50 rph-1 
 
(Blattner, 1997) 
DH5 a l pir sup E44, ΔlacU169 (ΦlacZΔM15), recA1, endA1, 
hsdR17, thi-1, gyrA96, relA1, λpir phage lysogen 
 
Laboratory collection 
S17-1 λpir lysogen of S17.1 (Tpr Smr thi pro hsdR− M+ 
recA RP4::2-Tc::Mu-km::Tn7) 
 
(Simon et al., 1983) 
A. baumannii   
57; WT; AB0057Km;  
 
AB0057 ∆km::FRT; Km susceptible 
 
(Crépin et al., 2018) 
57 eV AB0057Km + pABBR_Km; KmR (Crépin et al., 2018) 
∆gna AB0057Km ∆gna This study 
∆gna eV AB0057Km ∆gna + pABBR_Km; KmR This study 
∆gna compl. AB0057Km ∆gna + pABBR_Km-gna; KmR This study 
∆gne2 AB0057Km ∆gne2 This study 
∆gne2 eV AB0057Km ∆gne2 + pABBR_Km; KmR This study 
∆gne2 compl. AB0057Km ∆gne2 + pABBR_Km-gne2; KmR This study 
∆gna-gne2 (∆a/e2) AB0057Km ∆gna-gne2 (∆a/e2) (Crépin et al., 2018) 
∆gna-gne2 (∆a/e2) eV AB0057Km ∆gna-gne2 (∆a/e2) + pABBR_Km; KmR This study 
∆gna-gne2 (∆a/e2) compl. AB0057Km ∆gna-gne2 (∆a/e2) + pABBR_Km-gna-
gne2 (a/e2); KmR 
This study 
AB5075 MDR Tibia/osteomyelitis isolate (Jacobs et al., 2014) 
AB5075 ∆wzc AB5075 ∆wzc (Tipton et al., 2018) 
AB5075 ∆pilT ABUW ∆3031::T26 
tnab1_kr121205p08q137 
(Gallagher et al., 
2015) 
   
Plasmids   
pCVD442_MCS 
 
pCVD442 + MCS; The IS1 element 
was swapped by a MCS; Apr, R6K, sacB 
(Crépin et al., 2018) 
pCVD_Km 
 




∆gna-gne2 (∆a/e2) in pCVD_AmK; Amkr, R6K, 
sacB 
(Crépin et al., 2018) 
pCVD_Km_∆gna ∆gna in pCVD_Km; Kmkr, R6K, sacB This study 
pCVD_Km_∆gne2 ∆gne2 in pCVD_Km; Kmkr, R6K, sacB This study 
pABBR_Km 
 
pABBR_MCS_Km; Kmr (Crépin et al., 2018) 
pABBR_Km-gna-gne2 
(a/e2) 
Genes gna-gne2 cloned into pABBR_Km; Kmr This study 
pABBR_Km-gna Gene gna cloned into pABBR_Km; Kmr This study 
pABBR_Km-gne2 Gene gne2 cloned into pABBR_Km; Kmr This study 
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S4 Table. Primers and oligonucleotides.   
Name Sequence 5’ ® 3’ Purpose 
Mutant   
GA_pCVD_Km_F GGCAGGTATATGTGATGGGTTAAAAAGGA Inverted PCR of pCVD_Km to clone, by Gibson assembly, the 
gene of interest (goi) GA_pCVD_Km_R GGCAACTTTATGCCCATGCAACA 
   
GA_gna_5’frag_F TAGTTTCTGTTGCATGGGCATAAAGTTGCCGCCTAAAGCATCCGTTAAAGTCAT Amplification of ~  1 Kb 








TAAATC Amplification of ~  1 Kb 
dowstream of gna 
GA_gna_3’frag_R CCTTTTTAACCCATCACATATACCTGCCGCCTGTGAATGCCTTACATCTCC 
delta_gna_screen ATAAGCTTACTGTCCCAAACGGTCTA 
Screening to confirm the gna 
mutation; used with 
GA_gna_3’frag_R 
   
GA_gne2_5’frag_F TCTGTTGCATGGGCATAAAGTTGCCGCCATTGGCAGTTGAGTTTGGA Amplification of ~  1 Kb 








GTCTTTG Amplification of ~  1 Kb 
upstream of gne2 
GA_gne2_3’frag_R CCTTTTTAACCCATCACATATACCTGCCGCCTGTGAATGCCTTACATCTCC 
delta_gne2_screen TTTACTGGAGGCGTAATTTCAGGGTATG 
Screening to confirm the gne2 
mutation; used with 
GA_gne2_3’frag_R 
   
pCVD_Screen_F GATTTGCAGACTACGGGCCTAAAG Screening to confirm the 
cloning of the ∆goi into 
pCVD_Km pCVD_Screen_R CGAACTAAACCCTCATGGCTAACG 
   




ACAGATTCTAGC  Cloning of the gna-gne2 locus 
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GA_pABBR_Km_R GCCTTCCCCATTATGATTCTTCTCG Inverted PCR of pABBR_Km to 
clone, by Gibson assembly, the 




TAAACGCAGGCTGAACAGATTCTAG Cloning, by Gibson assembly, 









Cloning, by Gibson assembly, 
of gne2, with the native 
promoter found upstream of 














Screening to confirm the 
cloning of the goi into 
pABBR_Km 
   
qRT-PCR   
ESR    
degP_F_qPCR GTAATCAGAGCACCTTCCGGTTTAG Amplification of a portion of 
degP degP_R_qPCR TGACTCGTTCATACCTAGGCGTTAT 
baeR_F_qPCR TGTTCACGTACCTTACGGCAAATC Amplification of a portion of 
baeR baeR_R_qPCR GGTCAGGATGCTTACACGAACTTT 
rstA_F_qPCR CGCCCACACTATCATCAACCAA 
Amplification of a portion of rstA 
rstA_R_qPCR GCACCCATTTCCAGACCAAGTA 
dsbA_F_qPCR GGGTAGTGTAATGGCAGCAGATTT Amplification of a portion of 
dsbA dsbA_R_qPCR GGTACTTCCACTTTGCCTGGATTG  
Bolded nucleotides denote restriction site. 
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